A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera-Reference-Cited by-同舟云学术

A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera

Published:2014-08-16 Issue:4 Volume:167 Page:541-546
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Lussana Federico¹,Carobbio Alessandra²,Randi Maria L.³,Elena Chiara⁴,Rumi Elisa⁴,Finazzi Guido¹,Bertozzi Irene³,Pieri Lisa⁵,Ruggeri Marco⁶,Palandri Francesca⁷,Polverelli Nicola⁷,Elli Elena⁸,Tieghi Alessia⁹,Iurlo Alessandra¹⁰,Ruella Marco¹¹,Cazzola Mario⁴,Rambaldi Alessandro¹,Vannucchi Alessandro M.⁵,Barbui Tiziano²

Affiliation:

1. Haematology and Bone Marrow Transplant Unit; Azienda Ospedaliera Papa Giovanni XXIII; Bergamo Italy

2. Research Foundation; Azienda Ospedaliera Papa Giovanni XXIII; Bergamo Italy

3. Department of Medicine -DIMED; University of Padua; Padua Italy

4. Department of Haematology; University of Pavia; IRCCS Policlinico S Matteo; Pavia Italy

5. Laboratorio Congiunto MMPC; Department of Experimental and Clinical Medicine; Azienda Ospedaliera Universitaria Careggi; University of Florence; Florence Italy

6. Department of Haematology; Ospedale di Vicenza; Vicenza Italy

7. Department of Haematology and Oncology; Institute of Haematology “Lorenzo e Ariosto Seràgnoli”; Bologna Italy

8. Division of Haematology; San Gerardo Hospital; Monza Italy

9. Haematology; Onclogy Department; Azienda Ospedaliera Arcispedale Santa Maria Nuova-IRCCS; Reggio Emilia Italy

10. Division of Haematology; Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico; Milano Italy

11. Haematology and Cell Therapy Department; University of Torino; for the Gruppo Italiano Malattie EMatologiche dell’Adulto (GIMEMA); Torino Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13080/fullpdf

Reference17 articles.

1. Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients;Barbui;American Journal of Hematology,2014a

2. Masked polycythemia Vera (mPV): results of an international study;Barbui;American Journal of Hematology,2014b

3. Masked polycythemia vera diagnosed according to WHO and BCSH classification;Barbui;American Journal of Hematology,2014c

4. Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study;Campbell;Lancet,2005

5. The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the “early” prepolycythemic phase of polycythemia vera and essential thrombocythemia;Gianelli;American Journal of Clinical Pathology,2008

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta‐analysis;American Journal of Hematology;2024-01-30

2. The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective;Leukemia Research;2024-01

3. Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group;Clinical and Experimental Medicine;2023-09-25

4. Prediction of thrombosis in polycythemia vera: Development and validation of a multiple factor-based prognostic score system;Research and Practice in Thrombosis and Haemostasis;2023-03

5. Masked Polycythemia Vera and Iron Deficiency in a Fertile-Age Woman;Cureus;2023-01-09